FBLG - FibroBiologics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.42 0.04 (10.41%)	---	0.0 (0.95%)	0.0 (0.82%)	0.0 (0.82%)	0.04 (9.68%)	0.02 (3.56%)	0.02 (3.56%)

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.12
Diluted EPS:: -0.12
Basic P/E:: -3.9058
Diluted P/E:: -3.9058
RSI(14) 1m:: 100.0
VWAP:: 0.47
RVol:: 1.7769

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.43 +0.01 (+1.17%)	Oct 15 09:52
1m	Price decrease 1m	0.42 -0.01 (-2.32%)	Oct 15 09:41
1m	Price increase 1m	0.44 +0.01 (+2.26%)	Oct 15 09:31
10m	Price increase 10m	0.44 +0.02 (+4.82%)	Oct 15 09:30
1m	Price increase 1m	0.44 +0.02 (+4.82%)	Oct 15 09:30